🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

AptarGroup raises dividend to $0.45 per share

EditorNatashya Angelica
Published 07/11/2024, 05:09 PM
ATR
-

CRYSTAL LAKE, Ill. - AptarGroup, Inc. (NYSE: NYSE:ATR), a global provider of a variety of drug delivery and consumer product solutions, has announced an increase in its quarterly cash dividend to $0.45 per share, marking a nearly 10% rise from its previous dividend.

This change elevates the annual dividend to $1.80 per share, with the upcoming payment scheduled for August 15, 2024, for shareholders on record as of July 25, 2024.

The company's President and CEO, Stephan B. Tanda, cited Aptar's consistent strong performance and the potential for future growth as the impetus for the dividend increase.

Over the past five years, Aptar has returned in excess of $780 million to its stockholders through dividends and share repurchases. With this latest increase, the company is poised to achieve its 31st consecutive year of augmented total annual dividends.

Aptar is set to hold a conference call to discuss its second quarter results for 2024 on Friday, July 26, 2024. The call, expected to last approximately one hour, will be accessible via live webcast on the company's investor relations webpage, with a replay available for a limited time following the event.

As a firm with a presence in 20 countries and employing over 13,000 individuals, Aptar specializes in innovative solutions for the pharmaceutical, beauty, food, beverage, personal care, and home care markets. Headquartered in Crystal Lake, Illinois, the company's commitment to market expertise and proprietary design has established it as a significant player in its field.

This press release includes forward-looking statements regarding future dividends, subject to risks and uncertainties that could cause actual results to differ. These statements reflect Aptar's current views and are made in accordance with safe harbor provisions. For further details on potential risks, refer to Aptar's filings with the Securities and Exchange Commission.

The information for this article is based on a press release statement from AptarGroup, Inc.

In other recent news, Aptar reported robust growth in Q1, with a 5% increase in core sales and a notable 30% rise in adjusted earnings per share (EPS) to $1.26. The company's Pharma segment stood out, showing strong performance, particularly in proprietary drug delivery systems.

Meanwhile, the Beauty segment held steady, maintaining its core sales. Aptar's leadership forecasts continued momentum into Q2, expecting an adjusted EPS between $1.30 and $1.38.

Investors should note that despite a 5% decrease in core sales due to a decline in beauty closures, positive impacts were observed across various segments in the Americas and Latin America. Aptar remains committed to enhancing shareholder value through strategic investments and cost management. The company also plans to reduce fixed costs and optimize its operational footprint.

These recent developments indicate a positive trajectory for Aptar, with a strong balance sheet boasting a leverage ratio of approximately 1.4. The company anticipates strong momentum to carry into the second quarter and beyond, driven by proprietary drug delivery systems and consumer dispensing. Despite some challenges in cash flow and core sales in certain areas, Aptar's overall outlook remains optimistic.

InvestingPro Insights

AptarGroup, Inc. (NYSE: ATR) has not only announced a dividend increase but also exhibits a compelling financial profile as per the latest metrics from InvestingPro.

With a steady market capitalization of $9.44 billion, the company's commitment to shareholder returns is further underscored by a P/E ratio of 29.91, which is considered attractive when paired with near-term earnings growth. Moreover, Aptar's price to book ratio stands at 4.01, reflecting the market's valuation of the company relative to its book value.

InvestingPro Tips highlight that Aptar has raised its dividend for 31 consecutive years, showcasing a consistent commitment to shareholder value. Three analysts have revised their earnings upwards for the upcoming period, indicating optimism about the company's financial prospects. This positive sentiment is a testament to Aptar's strong market position and the potential for continued growth.

For investors seeking more in-depth analysis, there are additional InvestingPro Tips available that could provide further insights into Aptar's performance and potential investment opportunities. Use coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, and unlock the full suite of tips and data to inform your investment decisions.

The company's robust financial health, as indicated by its ability to sustain dividend payments over an extended period, is a critical factor for investors to consider. As Aptar prepares to share its second-quarter results and continues to expand its global footprint, these metrics and tips from InvestingPro offer valuable context for both current and prospective shareholders.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.